Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores

Autor: Adrien De Voeght, Evelyne Willems, Sophie Servais, Laurence Seidel, Michelle Pirotte, Paul Massion, Nathalie Layios, Maguy Pereira, Benoit Misset, Jean-Luc Canivet, Yves Beguin, Frédéric Baron

Publikováno v: Cancers; Volume 14; Issue 17; Pages: 4266

Background. Allogeneic hematopoietic stem cell transplantation (allo-HCT) recipients requiring intensive care unit (ICU) have high mortality rates. Methods. In the current study, we retrospectively assessed whether the Prognostic Index for Critically

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee26edc7521b58f640cfeac4c82aa24

Modalités de capture des anomalies cytogénétiques et moléculaires pour la leucémie aiguë, le myélome multiple, le syndrome myélodysplasique, le syndrome myéloprolifératif et le syndrome myélodysplasique/myéloprolifératif : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Autor: Carole Dantin, Micheline Karam, Ibrahim Yakoub-Agha, Nicole Raus, Maguy Pereira, Anne Wallart, Réda Chebel, Micha Srour

Publikováno v: Bulletin du Cancer. 107:S52-S61

In an effort to standardize hematopoietic stem cell allograft procedures, the Francophone bone marrow transplantation and Cell Therapy Society (SFGM-TC) organized the 9th Allograft Harmonization Practice Workshop in Lille in September 2018. The purpo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::78b43ccef0a951b6971ae1368189ad81
https://doi.org/10.1016/j.bulcan.2019.07.007

[A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

Autor: Florence, Broussais, Alyette, Vasseur, Micheline, Karam, Delphine, Chaillou, Maguy, Pereira, Ibrahim, Yakoub-Agha, Nicole, Raus

Publikováno v: Bulletin du cancer. 108(12S)

Tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™) are the first representatives of a new class of gene therapies produced by ex-vivo genetic modification of human autologous T lymphocytes, now using viral vectors. In 2020, there

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d491b9044a2b6a699109f6af75584c7d
https://pubmed.ncbi.nlm.nih.gov/33933288

Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple

Autor: Marie Robin, Marie-Thérèse Rubio, Stéphanie Nguyen, Jean-Hugues Dalle, Bénédicte Bruno, Jacques-Olivier Bay, Sophie Caillat-Zucman, Fabienne Colledani, Etienne Baudoux, Maguy Pereira

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (4), pp.408-409. ⟨10.1016/j.bulcan.2020.03.002⟩
Bulletin du Cancer, 2020, 107 (4), pp.408-409. ⟨10.1016/j.bulcan.2020.03.002⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b399c5a18bcb2f65555d1392a3e3403
https://hal.uca.fr/hal-02870571

[Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

Autor: Alyette, Vasseur, Micheline, Karam, Delphine, Chaillou, Elodie, Colonnese, Carole, Dantin, Christelle, Latiere, Youcef, Meziane, Maguy, Pereira, Ibrahim, Yakoub-Agha, Christian, Chabannon, Nicole, Raus

Publikováno v: Bulletin du cancer. 107(12S)

Tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™) are the first two approved drug products that belong to of a new class of therapies manufactured through an industrial process that includes the ex vivo genetic modification of h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::abaeb200a03f7c8938284555bad493db
https://pubmed.ncbi.nlm.nih.gov/31831153